Glipzy MP 2mg/500mg/15mg Tablet ER
Marketer
Apa Pharmaceuticals
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glipzy MP 2mg/500mg/15mg Tablet ER
Metformin-glimepiride-pioglitazone extended-release tablets (2mg/500mg/15mg) are a triple-combination medication managing blood glucose in adults with type 2 diabetes. Used adjunctively with diet and exercise, this medication enhances insulin effectiveness, thus reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen; take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Overdosage risks hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or meal skipping may precipitate hypoglycemia; regular blood glucose monitoring is crucial. Common adverse effects encompass nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician. Renal function assessment will precede treatment initiation. Limit alcohol consumption as it may heighten the risk of side effects.
Uses of Glipzy MP 2mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of Glipzy MP 2mg/500mg/15mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Glipzy MP 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Glipzy MP 2mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glipzy MP 2mg/500mg/15mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glipzy MP 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
How Glipzy MP 2mg/500mg/15mg Tablet ER works:
Glipzy MP 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood sugar management when single or dual medications prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glipzy MP 2mg/500mg/15mg Tablet ER with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glipzy MP 2mg/500mg/15mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glipzy MP tablets (2mg/500mg/15mg) are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk with the possibility of infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Glipzy MP 2mg/500mg/15mg ER tablets to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not receive this medication. Close monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glipzy MP 2mg/500mg/15mg Tablet ER cautiously, potentially requiring dose modification. Consult a physician before use. Glipzy MP 2mg/500mg/15mg Tablet ER is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glipzy MP 2mg/500mg/15mg Tablet ER :
Should you forget a Glipzy MP 2mg/500mg/15mg Tablet ER dose, take it promptly. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glipzy MP 2mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently